EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial

Riccardo Bertolo iD, Valerio Iacovelli iD, Chiara Cipriani iD, Marco Carilli, Matteo Vittori, Michele Antonucci, Francesco Maiorino, Marta Signoretti, Filomena Petta, Stefano Travaglia, Massimo Panei, Pierluigi Bove

BJU International · 2023-07 · 132 (1) · 100-108

DOI: 10.1111/bju.16008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJU International, online erschienen am 30.03.2023. Verfasst von Riccardo Bertolo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, San Carlo di Nancy Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Transurethral Resection of Prostate, Prostatic Hyperplasia, Urethral Obstruction, Laser Therapy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the reliability of transperineal interstitial laser ablation of the prostate (TPLA) in preserving antegrade ejaculation compared to transurethral resection of the prostate (TURP). Patients and Methods In this single‐centre, prospective, randomized, open‐label study, consecutive patients with indication for surgical treatment for benign prostatic obstruction (BPO) were enrolled between January 2020 and September 2021 (NCT04781049). Patients were randomized to one of two treatment arms: Group A: TPLA (experimental group) and Group B: TURP (reference standard group). The primary endpoint was change in ejaculatory function (assessed by the Male Sexual Health Questionnaire – Ejaculatory function domain [EJ‐MSHQ]) at 1 month after surgery. Secondary endpoints included comparison of visual analogue scale (VAS) scores, changes in sexual function (assessed using the five‐item International Index of Erectile Function [IIEF‐5]), change in International Prostate Symptom Score [IPSS], change in quality of life score, and maximum urinary flow rate [ Q max ] improvement at 1–6 months, as appropriate.

Results

Fifty‐one patients (26 TPLA vs 25 TURP) were analysed. No differences in the perception of pain assessed by VAS and no differences in IIEF‐5 score were found between the groups. The distribution of ejaculatory function assessed by the EJ‐MSHQ remained unmodified after TPLA ( P = 0.2), while a median 30% decrease in EJ‐MSHQ score was observed after TURP ( P = 0.01). Absence of antegrade ejaculation was reported in one patient in the TPLA group (vs 18 patients in the TURP group). A statistically significant difference between the treatment groups was found in terms of postoperative Q max (TPLA vs TURP: 15.2 [interquartile range 13.5–18.3] mL/s vs 26.0 [interquartile range 22.0–48.0] mL/s; P < 0.001). Both treatments significantly improved Q max , with a mean 23.9 mL/s improvement after TURP (95% confidence interval [CI] 17.1–30.7) vs 6.0 mL/s after TPLA (95% CI 5.0–7.0), and IPSS, with a mean decrease of 11.6 (95% CI 9.7–13.5) vs 5.8 after TPLA (95% CI.2–9.6) with respect to baseline.

Conclusion

In our study, TPLA preserved ejaculatory function in 96% of cases in addition to providing significant relief from BPO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transurethral Resection of ProstateProstatic HyperplasiaUrethral ObstructionLaser TherapyHumansMaleEjaculationProspective StudiesQuality of LifeReproducibility of ResultsTreatment Outcome

Stichwörter der Autor:innen

LUTSTPLATURPbenign prostatic hyperplasiabenign prostatic obstructionlaserminimally invasive surgerytechnology

Autor:innen und Institutionen

  • Department of Urology, San Carlo di Nancy Hospital, Rome, Italy.
  • Department of Life, Health and Environmental Sciences, Urology Unit, University of L'Aquila, Coppito, Italy.
  • Urology Unit, Department of Surgery, Tor Vergata University of Rome, Rome, Italy.

ORCID-Profile: Riccardo Bertolo, Valerio Iacovelli, Chiara Cipriani

Zitieren

APA

Bertolo, R., Iacovelli, V., Cipriani, C., Carilli, M., Vittori, M., Antonucci, M., Maiorino, F., Signoretti, M., Petta, F., Travaglia, S., Panei, M., & Bove, P. (2023). Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial. BJU International, 132(1), 100-108. https://doi.org/10.1111/bju.16008

Vancouver

Bertolo R, Iacovelli V, Cipriani C, Carilli M, Vittori M, Antonucci M, et al. Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial. BJU International. 2023;132(1):100-108. doi:10.1111/bju.16008

BibTeX
@article{Bertolo2023,
  author = {Bertolo, Riccardo and Iacovelli, Valerio and Cipriani, Chiara and Carilli, Marco and Vittori, Matteo and Antonucci, Michele and Maiorino, Francesco and Signoretti, Marta and Petta, Filomena and Travaglia, Stefano and Panei, Massimo and Bove, Pierluigi},
  title = {Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial},
  journal = {BJU International},
  year = {2023},
  volume = {132},
  number = {1},
  pages = {100--108},
  doi = {10.1111/bju.16008}
}
Kostenlos starten →